Adam Lerner

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

Sean Whittaker, Marie‐France Demierre, Ellen J. Kim et al. · Journal of Clinical Oncology · 2010 · 650 citations

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 621 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Medicine +6

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

H. Miles Prince, Youn H. Kim, Reinhard Dummer et al. · The Lancet · 2017 · 569 citations

Hematological Malignancy, Lymphoid Neoplasia, Medicine +9

De novo NAD+ biosynthetic impairment in acute kidney injury in humans

Ali Poyan Mehr, Mei Tran, Kenneth M. Ralto et al. · Nature Medicine · 2018 · 344 citations · Full text

Urology, Renal Function, Medicine +11

Pgp‐1^hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A

Adam Lerner, Takatsugu Yamada, Richard A. Miller · European Journal of Immunology · 1989 · 276 citations